BioCentury | Sep 21, 2015
Company News

GlobeImmune cancer news

...In August, GlobeImmune hired Cantor Fitzgerald & Co. to evaluate strategic options, including a merger or sale of all...
BioCentury | Jun 16, 2014
Company News

Celsion, Egen deal

...boards of both companies have approved the deal, which is expected to close this month. Cantor Fitzgerald & Co....
BioCentury | Sep 9, 2013
Financial News

NewLink financial update

...NewLink established an at-the-market program to sell up to $60 million of its common stock. Cantor Fitzgerald & Co....
Items per page:
1 - 3 of 3
BioCentury | Sep 21, 2015
Company News

GlobeImmune cancer news

...In August, GlobeImmune hired Cantor Fitzgerald & Co. to evaluate strategic options, including a merger or sale of all...
BioCentury | Jun 16, 2014
Company News

Celsion, Egen deal

...boards of both companies have approved the deal, which is expected to close this month. Cantor Fitzgerald & Co....
BioCentury | Sep 9, 2013
Financial News

NewLink financial update

...NewLink established an at-the-market program to sell up to $60 million of its common stock. Cantor Fitzgerald & Co....
Items per page:
1 - 3 of 3